Gaurav Kharya/LinkedIn
Jun 24, 2026, 16:49
Gaurav Kharya: Bridging the Gap in Safe Blood Access for Patients Who Can’t Wait
Gaurav Kharya, Director, Dept. of Bone Marrow Transplant and Cellular Therapy at Indraprastha Apollo Hospitals, shared a post on LinkedIn:
“Some issues cannot wait.
Access to safe blood for people who depend on regular transfusions is one of them-because delays can have life-threatening consequences.
My article in The Week looks at why ensuring timely and safe blood access remains critical, and why sustained attention and action are needed for those who rely on it every day.
Indraprastha Apollo Hospitals, New Delhi Cellogen Therapeutics
Bridging the gaps: Safe blood, lifesaving care, and a cure for sickle cell disease – The Week.”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 16:40William Wallace: Vitamin C and Collagen Work as One Biological System
-
Jun 24, 2026, 16:32Arlindo Nascimento de Lemos Junior: Thrombus Echogenicity as a Predictor of Post-Thrombotic Syndrome Severity After DVT
-
Jun 24, 2026, 16:09Jimi Olaghere: The Future of Sickle Cell Disease Research Starts With Collaboration
-
Jun 24, 2026, 16:03Von Willebrand Disease as a Common Yet Under-Recognised Bleeding Disorder – EHC
-
Jun 24, 2026, 15:57Maia Meier: Women with Bleeding Disorders Reach the Summit of Mont Blanc
-
Jun 24, 2026, 15:40Annette Bowyer: The Emerging Role of Extravascular Factor VII in Haemostasis
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss